Kyushu University · Faculty of Medicine / Graduate School of Medical Sciences

Research keywordsinfluenza antivirals・neuraminidase inhibitors・SARS-CoV-2 Omicron・rapid antigen testing・mRNA vaccine response・viral load correlation・immunocompromised patients

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• In vitro neuraminidase inhibitory concentrations (IC50) of four neuraminidase inhibitors in the Japanese 2023–24 season: Comparison with the 2010–11 to 2022–23 seasons2025 · Journal of Infection and Chemotherapy 31 ( 3 ) 2025年3月 （ ISSN: 1341321X ）
• Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications2024 · BMC Infectious Diseases 24 ( 1 ) 2024年12月
• In vitro neuraminidase inhibitory concentrations (IC50) of four neuraminidase inhibitors in the Japanese 2022–23 season: Comparison with the 2010–11 to 2019–20 seasons2024 · Journal of Infection and Chemotherapy 30 ( 3 ) 266 - 270 2024年3月 （ ISSN: 1341321X ）
• Virological and clinical outcomes in outpatients treated with baloxavir or neuraminidase inhibitors for A(H3N2) influenza: A multicenter study of the 2022–2023 season2024 · Antiviral Research 224 2024年4月 （ ISSN: 01663542 ）

• インフルエンザ患者から分離されたウイルスの全ゲノム解析によるワクチン効果の検討2014 · 研究課題/領域番号： 26461505 2014年 - 2016年

• Official profile